Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate

Pharmacotherapies for the treatment of Benign Prostatic Hyperplasia (BPH) are targeted at reducing cellular proliferation (static component) or reducing smooth muscle tone (dynamic component), but response is unpredictable and many patients fail to respond. An impediment to identifying novel pharmac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Lee, Sophie N., Kraska, Jenna, Papargiris, Melissa, Teng, Linda, Niranjan, Birunthi, Hammar, Johanna, Ryan, Andrew, Frydenberg, Mark, Lawrentschuk, Nathan, Middendorff, Ralf, Ellem, Stuart J., Whittaker, Michael, Risbridger, Gail P., Exintaris, Betty
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973579/
https://ncbi.nlm.nih.gov/pubmed/33737570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85439-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky